On Monday, Shares of Immune Pharmaceuticals Inc (NASDAQ:IMNP), subtract -4.03% and closed at $0.243 in the last trading session. IMNP stock opened its last trade at $-4.03 and after floating in a range of $0.24 to $0.27. The company’s Market capitalization is $26.92 million with the total Outstanding Shares of 101.58 million. During the 52-week trading session the minimum price at which share price traded, registered at $0.20 and reached to max level of $1.54. Immune Pharmaceuticals Inc. (IMNP) (“Immune”) declared recently that it has reached a consulting agreement with Joseph V. Pergolizzi Jr., MD. Dr. Pergolizzi will form an operational administration team, a Scientific Advisory Board, and a Board of Directors for Maxim Pharmaceuticals (“Maxim”), Immune’s pain and neurology partner, in order to advance the development of Amiket®. Maxim holds the rights to AmiKet, AmiKet NanoTM, and LidoPain® and will seek additional pain and neurology assets, preferably with 505(b)(2) development path possibilities.
Dr. Pergolizzi commented: “There is a noteworthyunmet medical need in the treatment of peripheral neuropathic pain. AmiKet, a topical, may be able to match the efficacy of certain oral drugs, with a convenient and potentially safer administration. I intend to bring to Maxim, with the active support of Immune’s CEO, Dr. Daniel Teper, a world class administration team with experience in development and commercialization of pain and neurology drugs.”
Dr. Pergolizzi is the co-founder and Chief Operating Officer of NEMA Research, a Clinical Research Organization, and president of Naples Anesthesia and Pain Associates of Naples, Florida. He has also held Chief Medical Officer positions at several pharmaceutical companies.
Prudential Financial Inc (NYSE:PRU), jumped 0.09% and closed at $84.51 in the last trading session. PRU stock opened its last trade at $84.62 and after floating in a range of $84.39 to $85.03. The company’s Market capitalization is $37.26 Billion with the total Outstanding Shares of 438.74 Billion. During the 52-week trading session the minimum price at which share price traded, registered at $57.19 and reached to max level of $88.77. Moffitt Cancer Center recently recommitted to Prudential Retirement as recordkeeper for five of its defined contribution plans, totaling $480 million in assets. Prudential Retirement is a business unit of Prudential Financial, Inc. (PRU).
Moffitt Cancer Center, the Florida-based leading cancer treatment and prevention center, has about 5,000 participants in the defined contribution plans covered under the renewed contract.
The retirement services provider began its partnership with Moffitt Cancer Center in 2007 when it signed on as its recordkeeper. Moffitt renewed its contract in August.
Underscoring a commitment to healthcare institutions
“We are happy to continue our partnership with long-time client Moffitt Cancer Center,” said Sean McLaughlin, senior vice president, Client Relations and Business Development for Prudential Retirement’s Full Service Solutions business. “In an increasingly competitive marketplace, we appreciate Moffitt’s confidence in the value we bring to their business and plan participants. Our renewed engagement underscores our deep understanding of issues facing healthcare institutions and ability to develop tailored solutions.”
Prudential Retirement provides defined contribution retirement plan solutions for about 615 plans in the healthcare sector, with $14.7 billion in assets under administration, counting Moffitt Cancer Center. Services to assist participants include onsite meetings, custom campaigns, an engagement hub, financial wellness seminars and a custom web portal.